Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 6
1982 7
1983 8
1984 50
1985 53
1986 73
1987 86
1988 96
1989 83
1990 82
1991 122
1992 78
1993 87
1994 121
1995 159
1996 134
1997 140
1998 118
1999 124
2000 111
2001 160
2002 134
2003 120
2004 130
2005 123
2006 152
2007 137
2008 169
2009 154
2010 183
2011 180
2012 174
2013 202
2014 168
2015 202
2016 199
2017 209
2018 192
2019 179
2020 188
2021 211
2022 164
2023 119
2024 60

Text availability

Article attribute

Article type

Publication date

Search Results

5,135 results

Results by year

Filters applied: . Clear all
Page 1
MIBG in neuroblastoma diagnosis and treatment.
Olecki E, Grant CN. Olecki E, et al. Semin Pediatr Surg. 2019 Dec;28(6):150859. doi: 10.1016/j.sempedsurg.2019.150859. Epub 2019 Nov 20. Semin Pediatr Surg. 2019. PMID: 31931960 Review.
Derived from sympathoadrenal cells of the adrenal medulla and sympathetic nervous system, both malignant neuroblastoma and differentiated tumors have specialized norepinephrine transporter (NET) receptors which are naturally occurring in the sympathetic nervous system throughout …
Derived from sympathoadrenal cells of the adrenal medulla and sympathetic nervous system, both malignant neuroblastoma and differentiated tu …
MIBG in Neuroblastoma Diagnostic Imaging and Therapy.
Sharp SE, Trout AT, Weiss BD, Gelfand MJ. Sharp SE, et al. Radiographics. 2016 Jan-Feb;36(1):258-78. doi: 10.1148/rg.2016150099. Radiographics. 2016. PMID: 26761540 Review.
MIBG uptake is seen in 90% of neuroblastomas, identifying both the primary tumor and sites of metastatic disease. ...Therapeutic use of MIBG labeled with iodine 131 ((131)I) is being investigated as part of research trials, both as a single agent and in conjunction
MIBG uptake is seen in 90% of neuroblastomas, identifying both the primary tumor and sites of metastatic disease. ...Therapeutic use
I-131-MIBG therapies.
Vöö S, Bucerius J, Mottaghy FM. Vöö S, et al. Methods. 2011 Nov;55(3):238-45. doi: 10.1016/j.ymeth.2011.10.006. Epub 2011 Oct 25. Methods. 2011. PMID: 22056346 Review.
Metaiodobenzylguanidine (MIBG) is a tracer that selectively targets neuroendocrine cells. ...Extensive work has been addressed to develop I-131-MIBG therapy: doses, therapeutic schemes, and efficiency. In this paper, we present an overview on I-131-MIBG thera …
Metaiodobenzylguanidine (MIBG) is a tracer that selectively targets neuroendocrine cells. ...Extensive work has been addressed to dev …
(123)I-mIBG: Simplicity and reproducibility.
Curl K, Hansen CL. Curl K, et al. J Nucl Cardiol. 2019 Oct;26(5):1566-1568. doi: 10.1007/s12350-018-1196-9. Epub 2018 Jan 29. J Nucl Cardiol. 2019. PMID: 29380284 No abstract available.
123I-MIBG Imaging: Patient Preparation and Technologist's Role.
Van Vickle SS, Thompson RC. Van Vickle SS, et al. J Nucl Med Technol. 2015 Jun;43(2):82-6. doi: 10.2967/jnmt.115.158394. Epub 2015 May 8. J Nucl Med Technol. 2015. PMID: 25956690 Free article. Review.
The radiopharmaceutical (123)I-metaiodobenzylguanidine (MIBG) was approved by the Food and Drug Administration in March 2013 for the assessment of myocardial sympathetic innervation in the evaluation of patients with heart failure and an ejection fraction of no more than 3 …
The radiopharmaceutical (123)I-metaiodobenzylguanidine (MIBG) was approved by the Food and Drug Administration in March 2013 for the …
(123)I-meta-iodobenzylguanidine (MIBG) cardiac scintigraphy in alpha-synucleinopathies.
Orimo S, Yogo M, Nakamura T, Suzuki M, Watanabe H. Orimo S, et al. Ageing Res Rev. 2016 Sep;30:122-33. doi: 10.1016/j.arr.2016.01.001. Epub 2016 Feb 2. Ageing Res Rev. 2016. PMID: 26835846 Review.
Cardiac meta-iodobenzylguanidine (MIBG) uptake on (123)I-MIBG cardiac scintigraphy is reduced in patients with Lewy body disease such as Parkinson's disease (PD), dementia with Lewy bodies (DLB), and pure autonomic failure, and has been reported to be useful for dif …
Cardiac meta-iodobenzylguanidine (MIBG) uptake on (123)I-MIBG cardiac scintigraphy is reduced in patients with Lewy body disea …
Radioiodinated metaiodobenzylguanidine (MIBG): radiochemistry, biology, and pharmacology.
Vallabhajosula S, Nikolopoulou A. Vallabhajosula S, et al. Semin Nucl Med. 2011 Sep;41(5):324-33. doi: 10.1053/j.semnuclmed.2011.05.003. Semin Nucl Med. 2011. PMID: 21803182 Review.
In 2008, (123)I-MIBG was also approved by FDA as a tumor imaging agent. Commercial formulations of radioiodinated MIBG are prepared on the basis of radioiodide exchange reaction with unlabeled MIBG as a precursor and contain large mass amounts of unlabeled …
In 2008, (123)I-MIBG was also approved by FDA as a tumor imaging agent. Commercial formulations of radioiodinated MIBG are pre …
MIBG Uptake in Pancreas as a Normal Variant.
Wang Y, Yang X, Wang W, Yang J. Wang Y, et al. Clin Nucl Med. 2022 Feb 1;47(2):168-171. doi: 10.1097/RLU.0000000000003782. Clin Nucl Med. 2022. PMID: 34183500
A 5-year-old girl with high-risk neuroblastoma underwent 123I-MIBG scintigraphy for disease restaging. The whole-body images showed a faint MIBG uptake in the midabdomen. ...However, this activity disappeared on delayed acquisition at 6-hour later. Follow-up MIBG
A 5-year-old girl with high-risk neuroblastoma underwent 123I-MIBG scintigraphy for disease restaging. The whole-body images showed a …
The evolution in the use of MIBG scintigraphy in pheochromocytomas and paragangliomas.
Rufini V, Treglia G, Perotti G, Giordano A. Rufini V, et al. Hormones (Athens). 2013 Jan-Mar;12(1):58-68. doi: 10.1007/BF03401287. Hormones (Athens). 2013. PMID: 23624132 Free article. Review.
Radioiodinated metaiodobenzylguanidine (MIBG) was developed in the late 1970's, at the Michigan University Medical Center, for imaging of the adrenal medulla and its diseases. Soon after, MIBG was shown to depict a wide range of tumors of neural crest origin other t …
Radioiodinated metaiodobenzylguanidine (MIBG) was developed in the late 1970's, at the Michigan University Medical Center, for imagin …
5,135 results